Certain plasma biomarkers of neuronal damage and neuroinflammation are markedly
elevated in hospitalized COVID-19 patients with neurologic symptoms, compared with …

Recently, some researchers claimed neuropathological changes lead to Alzheimer's-like
brains after severe infection of SARS-CoV-2. Several mechanisms have been postulated on …

We thank Dr. Lozada et al. for their commentary. We agree that our findings demonstrated
clearly the significant increased risk for COVID infection and for poor outcomes for patients …

article in brief: A study in the Journal of Alzheimer's & Dementiareported that hospitalized
COVID-19 patients were at significant risk of brain injury and inflammation, as well as …

Abstract Coronavirus disease 2019 (COVID‐19) has rapidly escalated into a global
pandemic that primarily affects older and immunocompromised individuals due to …

Background SARS‐CoV‐2 the causative agent of COVID‐19 displays a broad range of
pathophysiology. Cytokine storms associated with COVID‐19 damage the blood‐brain …

Abstract Introduction Coronavirus disease 2019 (COVID‐19) has caused> 3.5 million deaths
worldwide and affected> 160 million people. At least twice as many have been infected but …

The link and association between COVID‐19 and Alzheimer's disease (AD) is controversial.
This study aims to investigate whether COVID‐19 was associated with a different presenting …

In light of the rising evidence of the association between viral and bacterial infections and
neurodegeneration, we aimed at revisiting the infectious hypothesis of Alzheimer's disease …

In elderly patients with COVID-19 cognitive functions decline; it has been suggested that
SARS-CoV-2 infection may lead to the development of Alzheimer's disease (AD) and other …